Hua Mao Wang
Founder bei CARSGEN THERAPEUTICS HOLDINGS LIMITED
Profil
Hua Mao Wang is the founder of Shanghai Ruijin Biotechnology Co. Ltd.
(founded in 2011), CARsgen Therapeutics Holdings Ltd.
(founded in 2018), and Yijie Biotech Shanghai Holding Ltd.
(founded in 2011).
Dr. Wang's current jobs include Chief Operating Officer at CARsgen Therapeutics Co. Ltd.
(since 2014) and General Manager at Carsgen Diagnostics Co. Ltd.
(since 2020).
Dr. Wang received a graduate degree from Fudan University in 2003 and a doctorate degree from the same university in 2009.
Aktive Positionen von Hua Mao Wang
| Unternehmen | Position | Beginn |
|---|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Founder | 09.02.2018 |
CARsgen Therapeutics Co. Ltd.
 CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Chief Operating Officer | 01.10.2014 |
| Carsgen Diagnostics Co. Ltd. | Chief Executive Officer | 01.11.2020 |
Ehemalige bekannte Positionen von Hua Mao Wang
| Unternehmen | Position | Ende |
|---|---|---|
| Shanghai Ruijin Biotechnology Co. Ltd. | Founder | 01.01.2013 |
| Yijie Biotech Shanghai Holding Ltd. | Chief Executive Officer | 01.10.2014 |
Ausbildung von Hua Mao Wang
| Fudan University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
CARsgen Therapeutics Co. Ltd.
CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Health Technology |
| Yijie Biotech Shanghai Holding Ltd. | |
| Shanghai Ruijin Biotechnology Co. Ltd. | |
| Carsgen Diagnostics Co. Ltd. |
